This Reprint showcases recent advancements in glaucoma diagnosis and treatment, featuring studies on deep learning for disease detection, genetic influences on progression, and links between systemic conditions like diabetes and glaucoma. It highlights the role of OCTA in assessing microvascular changes, immune responses in glaucoma, and outcomes of minimally invasive surgeries. Additionally, the articles within the Reprint explore the therapeutic potential of nicotinamide, novel structural biomarkers, and sensory disturbances related to glaucoma. This Reprint serves as a valuable resource for clinicians and researchers seeking the latest insights in glaucoma care.